Series B funding round for Reneo Pharmaceuticals raising $95M in December 2020
Series B funding round for Reneo Pharmaceuticals raising $95M in December 2020
| Investor | Firm Type | Partner |
|---|
Novo VenturesLEAD | Venture Capital | — |
AbingworthLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Ed Mathers |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$145M
Top Valuation
-
Reneo Pharmaceuticals raised $95M in a Series B round.
The round was announced on 12/01/20.
The round was led by Abingworth, Ken Harrison.